PROGRAM | Scientific Program
   
  Nov. 4, Friday
Time Program Venue
13:00-14:00  

Special Lecture 1                                       10F, Auditorium
Session 1:    Basic Research and Immunotherapy  
13:00-13:20    Vaccination with Short-term Glioma Tumor Cells co-Cultivated with Autologous
Dendritic Cells

Chen-Nen Chang / Chung Gung Memorial Hospital, Taiwan
 
13:20-13:40    Recombinant Antibody-based Molecular Therapeutics for Brain Tumor Immunotherapy
Chien-Tsun Kuan / Duke University Medical Center, USA
 

13:40-14:00   
Basic Research Field of Neuro-Oncology
Jianhong Zhu/ China
 
14:00-15:10   Special Lecture 2
10F, Auditorium
Session 2:    Epidemiology  
14:00-14:20    The Time Trend of Various Primary Brain Tumor Incidence in Japan 1973-1993
Kazuhiro Nomura / Natinal Cancer Center Hospital, The Committee of Brain Tumor Registry of Japan, NCC Research Institute, Japan
 
14:20-14:40 Epidemiology of Glial Tumors/High Grade Supratenorial Glial Tumors Epidemiology and in our Experience
Kaya Aksoy / Uludag University Department of Neurosurgery BURSA, TURKEY
 
14:40-14:55 Primary Pediatric Brain Tumors: A Hospital Series of Taipei VGH, Taiwan(1975-2004)
Tai-Tong Wong / Taipei Veterans General Hospital, Taiwan
 
14:55-15:10    Epidemiology of Intracranial Neoplasms at the Philippine General Hospital
Gerardo Legaspi / c/o Schering Plough Corporation, Philippines
 
15:10-15:20 Coffee Break 10F, Chang Chin Room
15:20-17:20 Keynote Speech I 10F, Auditorium
Session 3: Surgical Strategy  
15:20-15:50    Surgery of Meningiomas from Basic to Skull Base Approaches
Shigeaki Kobayashi / Shinshu University, Japan
 
15:50-16:20    Current Management of Craniopharyngiomas
Concezio Dirocco / Italy
 
16:20-16:50    Immunotherapy of Brain Tumors
Darell Bigner / Duke University Medical Center Durham, USA 
 
16:50-17:20    Molecular Diagnosis, Targeting and Management of Pediatric Brain Tumors
James Rutka / The Hospital for Sick Children, Canada
 
17:20-18:15 Special Lecture 3 & Oral Presentation 1 10F, Auditorium
Session 4: Surgical Strategy  
17:20-17:40 The Application of EC-IC Bypass in the Treatment of Skull Base Lesions
Dae-Hee Han / Seoul National University College of Medicine, Korea
 
17:40-18:00   What Neurosurgeons could do for Brain Tumor Patients? Experience at Tumor Hospital of Sun Yat-sen University
Zhongping Chen / Sun Yat-sen University, China
 
18:00-18:15 Modified Occipital Transtentorial Approach to the Pineal Region
Sang-Won Lee / The Catholic University of Korea, Korea
 
14:30-16:30 Oral Presentation 2                               1F, Inter Reception Hall
Session 5: Basic Research and Immunotherapy  
14:30-14:45   Preliminary Study of Local Immunotherapy for Glioma Patient with Autologous Cytokine-induced Killer Cells
Li Lin / Sun Yat-sen University, China
 
14:45-15:00   Immunotherapy Targeting WT1 Gene Product for Patients with Recurrent or Refractory Malignant Gliomas
Shuichi Izumoto / Osaka University Medical School, Japan
 
15:00-15:15   Immunotherapy for Glioma Cells in Rats
Sheng-Hong Tseng / National Taiwan University Hospital and National Taiwan University College of Medicine, Taiwan
 
15:15-15:30   Enhancement of Anti-tumor Immunity Specific to Murine Glioma by Vaccination with
Tumor Lysate

Yong-Kil Hong / The Catholic University of Korea, Korea
 
15:30-15:45     Proteomics-based Identification of an Autoimmune Antigen of Glyceraldehydes-
3-phosphate Dehydrog

Xinyu Yang / Tokyo Women's Medical University, Japan
 
15:45-16:00   Autotaxin is Overexpressed in Glioblatoma Multiforme and Contributes to Cell Motility of Glioblastoma
Takamitsu Fujima / The University of Tokyo, Japan
 
16:00- 16:15    Prognostic Significance of Annexin VII Expression in Human Glioblastoma
Kuo-Sheng Hung / Chang Gung Memorial Hospital and University, Taiwan
 
16:15-16:30   The Phosphorylation Status of Merlin is Important in the Regulation of the Ras-ERK Signaling Pathway
Sin-Soo Jeun / Chang Gung Memorial Hospital and University, Taiwan
 
16:30-16:45   Experimental Study of Angiostatin cDNA for Glioma
Pang Qi / Shandong University, China
 
Nov. 5, Saturday
Time Program Venue
07:20 - 08:10

Oral Presentation 3 10F, Auditorium
Session 6:   Gamma Knife Radiosurgery  
07:20-07:35    Gamma Knife Radiosurgery for Low-grade Astrocytomas:
Long-term Outcome

Ling-Wei Wang / Taipei Veterans General Hospital, Taiwan
 
07:35-07:50   Meningioma Radiosurgery: A Long Term Follow-Up Study on Tumor Control and Recurrence
Chung-Jung Lin / National Yang-Ming University, and Tamkang University, Taiwan
 
07:50-08:05   Principles of Gamma Knife Radiosurgery in Tumors Adjacent to Optic Apparatus Tzu-Wen Loh / Buddhist Tzu-Chi Medical Center and Tzu-Chi University, Taiwan  
08:10 - 08:30 Opening Ceremony 10F, Auditorium
08:30 - 09:50  Keynote Speech II & Special Lecture 4                       10F, Auditorium
Session 7:    
08:30-09:00  Treatment of Glioma in Children
Yukitaka Ushio / Otemae Hospital, Japan
 
09:00-09:30  Diagnosis and Surgical Treatment of Brainstem Hemangioblastomas (33 Patients)
Liang-Fu Zhou / Huashan Hospital, Fudan University, China
 
09:30-09:50  Treatment Results of Intracranial Germ Cell Tumors - Final Results of Japanese Study Group for CNS Germ Cell Tumors
Masao Matsutani / Saitama Medical School, Japan
 
09:50 - 10:00  Coffee Break 10F, Chang Chin Room
10:00 - 11:00 Special Lecture 5 10F, Auditorium
Session 8:   Gamma Knife RS  
10:00-10:20  Radiosurgical Results of Gamma Knife Radiosurgery for Benign Tumors involving Cavernous Sinus
Yang Kwon / Asan Medial Center, Ulsan University, Korea
 
10:20-10:40      Gamma Knife Radiosurgery for Vestibular Schwannomas
Seiji Fukuoka / Nakamura Memorial Hospital, Japan
 
10:40- 11:00 Gamma-Knife radiosurgery for Trigerminal Neuroma-long –term follow-up   
Wen-Yuh Chung / Taiwan
 
11:00 -12:05

Special Lecture 6 & Oral Presentation 4                       10F, Auditorium
Session 9:    Neuroradiology  
11:00-11:20   Improved Workflow in Radiosurgery and Stereotactic Radiotherapy by Using Intraoperative MRI Data
Granslandt Oliver / University Erlangen, Germany
 
11:20- 11:35   DTI of Brain Tumor
Yao-Hung Wang / Taiwan
 
11:35- 11:50    Application of Intervention Technique in Pediatric Neurosurgery
FC Chang / Taipei Veterans General Hospital, Taiwan
 
11:50- 12:05   Predict the Post-surgical Outcome of Brain Tumor Using Diffusion MRI/MR Diffiusion Tensor Imaging
Ching-Po Lin / National Taiwan University, Taiwan
 
12:05 - 12:30 Lunch                                            10F, Chang Chin Room
12:30 - 13:30 Luncheon Keynote Speech I                                10F, Auditorium
Session 10:  Neuroimaging  
12:30-13:00   Translational Molecular Imaging in Neuro-Oncology
Juri G. Gelovani / USA
 
13:00-13:30   Physiological brain tumor imaging: implications for diagnosis and management
Michael H. Lev / Massachusetts General Hospital, USA
 
13:30- 14:30   

Special Lecture 7                                          10F, Auditorium
Session 11:  Neuroimaging  
13:30-13:50    Impact of Neuromagnetic Functional Mapping for Treatment of Glioma
Nobukazu Nakasato / Kohnan Hospital, Japan
 
13:50-14:10   Glioma Removal with Advanced Modern Technology
Tomokatsu Hori / Tokyo Woman's Medical University, Japan
 
14:10-14:30   3T MR Spectroscopy and Diffusion imaging: Parameter Consideration for Glioma Grading
Dong Gyu Na / Seoul National University Hospital, Korea
 
14:30- 14:40  Coffee Break                                        10F, Chang Chin Room
14:40- 16:50 Special Lecture 8 & Oral Presentation 5 10F, Auditorium
Session 12:   Pituitary Tumors  
14:20-15:00    Transnasal Pituitary Surgery with Endoscope Assistance
Tomokatsu Hori / Tokyo Woman's Medical University, Japan
 
15:00-15:20   Tumor Tissue Identification on the Pseudocapsule of Pituitary Adenoma by Frozen Biopsy
Sun Ho Kim / Yonsei University College of Medicine, Korea
 
15:20- 15:40  Gamma Knife Radiosurgery for Pituitary Adenoma
Maheep Singh Guar / Head, Gamma knife Radiosurgery, India
 
15:40-16:00     MIB-1 Labeling Index Correlated with MRI Detected Tumor Volume Doubling Time in Pituitary Adenoma
Donald Ming-Tak Ho / Taiwan
 
16:00-16:15     Endoscopic Transsphenoidal Surgery with Intraoperative Hormone Monitoring Contributes to Increase the Cure Rate of Functioning Pituitary Adenomas
Shigetoshi Yano / Kumamoto University Graduate School, Japan
 
16:15-16:30     Hypothalamic Hamartoma: A review of the Role of Surgery in its Management
Dawson Fong / China
 
16:30-16:50     Application of Endoscopy to Neuro-oncology
Charles Teo / Centre for Minimally Invasive Neurosurgery, Australia
 
16:50- 18:10

Special Lecture 9 10F, Auditorium
Session 13:  Basic Research  
16:50-17:10 Current Views of Two Important Biological Aspects of the Progression of Brain Tumors, Angiogenesis
Shi-Yuan Cheng / University of Pittsburgh Cancer Institute, USA
 
17:10-17:30   Correlation of Proliferative Capacity (MIB-1) and Angiogenesis (VEFG and bFGF) in Histological Subtypes of Meningothelial Tumors
Aydin Sav / Marmara University, Turkey

 
17:30-17:50   Molecular Understanding and Dynamic Analysis of Anti-cancer Therapy  Hideyuki Saya / Kumamoto University School of Medicine, Japan  
17:50-18:10    Randomized Controlled Trial on Malignant Gliomas by JCOG-Brain Tumor Study Group
Soichiro Shibui / National Cancer Center Hospital, Japan
 
14:30- 16:30  Business Meeting                                            1F, Room 107
10:00- 12:00

Special Lecture 10 & Oral Presentation 6                     12F, Sky Lounge
Session 14:  Craniopharyngioma  
10:00-10:10    Introduction to current concept of craniopharyngioma management
Concezio Dirocco / Italy
 
 10:10:10:30   Surgical treatment for tumors of third and lateral ventricles
Hajime Arai / Juntendo University, Japan
 
10:30-10:50   Surgical management of craniopharyngiomas in children
Byung-Kyu Cho / Seoul National University Hospital, Korea
 
10:50-11:05    Surgical approach and functional prognosis of large adult craniopharyngiomas
Katsushi Taomoto / Ohnishi Neurological Center, Japan
 
11:05-11:20    Endoscopy assisted transsphenoidal transcisternal approach for craniopharyngioma Sun Ho Kim / Yonsei University College of Medicine, Korea  
11:20-11:40    Craniopharyngiomas:  Predictive Factors of Recurrence
Joong-Uhn Choi / Yonsei University College of Medicine, Korea
 
11:40-12:00  Gamma Knife Radiosurgery for Craniopharyngioma
Kang-Du Liu /
 
12:00- 12:30  Lunch 10F, Chang Chin Room
12:30- 14:30 Oral Presentation 7                                       12F, Sky Lounge
Session 15:  Surgery  
12:30-12:45  Surgery of Eloquent Area Gliomas with Integrated Navigation System
Takanori Ohnishi / Ehime University School of Medicine, Japan
 
12:45-13:00  Motor Cortical Mapping-Awake Procedure is Preferable to General Anaesthesia
in Cerebral Tumor Resection
Danny Tat Ming Chan / The Chinese University of Hong Kong, China
 
13:00-13:15   Low Grade Gliom Associated Intractable Epilepsy: Lesionectomy versus Epilepsy Surgery
Sin-Soo Jeun / Catholic unversity of Korea, Korea
 
13:15-13:30  The relationship Between Histopathological Findings and 5-aminolevulinic Acid Induced Fluorescence in Glioma Surgery
Yoshinaga Kajimoto / Osaka Medical College, Japan
 
13:30-13:45  5-aminolevurinic Acid (ALA) Induced, Fluorescence Guided Surgery: Application to Glioma and Meningioma
Naoya Hashimoto / Osaka University Medical School, Japan
 
13:45-14:00   Preliminary Observations on New Treatment Considerations for High-Grade Astrocytoma (HGA)
Mizuhiko Terasaki / Kurume University School of Medicine, Japan

 
14:00-14:15  Antiangiogenetic factor – K1-5 in the Treatment of Malignant Glioma
Ming-Chao Huang / Taipei Veteran General Hospital, Taiwan
 
14:15-14:30  Neurosurgical Managements of Central Neurocytoma
Hideo Takeshima / Kumamoto University, Japan
 
14:40- 16:10 Special Lecture 11 & Oral Presentation 8 12F, Sky Lounge
Session 16:  Meningioma  
14:40-15:00    Microsurgical Treatment of Tuberculum Sellae Meningiomas
Jiangkang Shen / Shanghai Second Medical University, China
 
15:00-15:15   Surgically Treated Tuberculum Sellae and Diaphragm Sellae Meningiomas: the Importance of Short-term Visual Outcome
Yong-Hwy Kim / Seoul National University College of Medicine, Korea
 
15:15-15:35    Surgical Treatment of Tuberculum Sellae Miningiomas - Role of Unroofing of the Optic Canal
Norio Arita / Hyogo College of Medicine, Japan
 
15:35-15:55  Keyhole Approach Surgery for Petroclival Meningiomas: Indications and Results
of 14 Cases
Ying Mao / Hua Shan Hospital, Fudan University, China
 
15:55-16:10  Postoperative Growth of Meningioma can be Predicted by MIB-1 Proliferative
Potential Study
Takamitsu Fujimaki / Tokyo University, Japan
 
16:10- 17:30 Special Lecture 12 & Oral Presentation 9 12F, Sky Lounge
Session 17:  Clivus,CVJ & Pineal regions, others  
16:10-16:30 Neurosurgical Perspective on Treatment and Outcome of Chordomas and Chondrosarcomas
Amir Samii / Germany
 
16:30-16:50  Endoscopic Transnasal Surgery of Clival Chordoma
Yu-Shu Yen / Taipei Veterans General Hospital, Taiwan
 
16:50-17:10  Surgical Approach to Benign Neoplasm of Cervical-Medullary Junction with Instrumentation-Six Cases
Henrich Cheng / Taipei Veterans General Hospital, Taiwan
 
17:10-17:25  Surgery of Benign Tumors in the Craniovertebral Junction
Shin Jung / Chonnam National University Hwasun Hospital, Korea
 
19:00-21:30 Banquet 12F, Grand Ballroom
Nov. 6, Sunday
Time Program Venue
07:20-08:10

Oral Presentation 10                                       10F, Auditorium
Session 18:  Basic Research  
07:20-07:35 Suppression of In Vivo Malignant Glioma Growth by the Kringle Domain of Urokinase Plasminogen Activator and Its combination Effect
Choong Kwon Kim / Catholic Research Institutes of Medical Sciences, Korea
 
07:35-07:50 Inhibition of 90-kD Heat Shock Protein Potentiates the Cytotoxicity of DNA-alkylating Agents on Human Glioma Cells
Shigeo Ohba / Keio University School of Medicine, Japan
 
07:50-08:05 Cystic Vestibular Schwannoma: Surgical Results & Expression of Matrix Metalloproteinases in the Cyst Fluids
Kyung-Sub Moon / Chonnam National University Hwasun Hospital & Medical School, Korea
 
08:05-08:20 Centrosome Abnormality: an Indicator of Increased Recurrence Risk in Benign Meningiomas
AS Lieu / Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
 
08:30-10:30 Keynote Speech III                                           10F, Auditorium
Session 19-1:   Chemotherapy  
08:30-09:00    Exploiting Mutations in Tumors for Targeted Therapy? Defective Receptor Signaling in Human Glioma: Mechanisms and Therapeutic Opportunities
Webster K Cavenee / University of California at San Diego, USA
 
09:00-09:30  Chemotherpay for Malignat Glioma: Cytotoxic and Targeted Therapies
Alfred Yung / MD Anderson, USA
 
09:30-10:30  

Keynote Speech IV                                         10F, Auditorium
Session 19-2:   Chemotherapy  
09:30-10:00 BCNU-Chemotherapeutic Wafers to Prevent Local Recurrence of Metastatic Cancer to the Brain
Steven Brem / H. Lee Moffitt Cancer Center & Research Institute, USF College of
Medicine , Tampa, FL, USA
 
10:00-10:30    Advances in the Management of Brain Metastases
Jong Hyun Kim / Sungkyunkwan University School of Medicine, Korea
 
10:30-10:40 Coffee Break 10F, Chang Chin Room
10:40-12:00 Special Lecture 13 10F, Auditorium
Session 20:   Therapeutic Strategy and Surgical Techniques  
10:40-11:10 New Therapeutic Strategy Against Malignant Brain Tumor Utilizing Liposome
Jun Yoshida / Nagoya University Graduate School of Medicine, Nagoya, Japan
 
11:10-11:30   Intraoperative Brain Mapping for Tumor Resection 
Moon-Chan Kim / Kangnam St. Mary's Hospital, Korea
 
11:30-12:00  Techniques to Maximise Glioma Resection with Minimal Morbidity
Wai Hoe Ng / Singapore                                                                     
 
12:00-12:30 Lunch 10F, Chang Chin Room
12:30-13:30  

Luncheon Speech II                                        10F, Auditorium
Session 21:  Vestibular Schwannoma  
12:30-12:50 Surgery for Acoustic Schwanoma
Vijendra Jain / India
 
12:50-13:10   Microhemorrhage is a Possible Mechanism for Cyst Formation in Vestibular Schwannomas
Hee Wong Jung / Seoul National University College of Medicine, Japan
 
13:10-13:30   Evaluation of Brain Stem Dysfunction by Blink Reflex in Patients with CP Angle Tumor
Hirotsune Kawamura / Department of Neurosurgery Tokyo Women's Medical University Daini Hospital, Japan
 
13:30-14:30  

Special Lecture 14 & Oral Presentation 11                     10F, Auditorium
Session 22:  Glioma and Medulloblstoma  
13:30-13:50  Research and Therapy of Medulloblastoma
Kazuo Tabuchi / Saga University, Japan
 
13:50-14:10   Reduced expression of REOT1 on 1p36.32 is Correlated with Chromosome 1p Loss in Oligodendroglial Tumours
Ho-Keung Ng / China
 
14:10-14:25   Anaplasia of Medulloablastoma and Its Impact on Clinical Features and Prognosis
Young-Shih Ra / Asan Medical Center, University of Ulsan, Korea
 
14:25- 14:40  Coffee Break                                        10F, Chang Chin Room
14:40- 16:10
Oral Presentation 12                                         10F, Auditorium
Session 23: Basic Research  
14:40-14:55   Germinal Center Associated Nuclear Protein Appears as a Molecular Marker of Primary Central Nervous System lymphoma
Keishi Makino / Japan Science and Technology Agency (JST), Japan
 
14:55-15:10   Monitoring the Growth Effect of Xenotransplanted Human Medulloblastoma in Immunocompromised Mice Model Using MRI Modality and Green Fluorescent Protein Imaging
Shi-Hwa Chiou / Taipei Veteran General Hospital, Taiwan
 
15:10-15:25   Migration and Differentiation of Bone Marrow Stromal Cells after Transplantation into Radiation-induced Brain Injury in Rat
SungBum Ahn / Korea University, Korea
 
15:25-15:40   A Novel Human Zinc Finger Gene is Hypermethylated in Tumors of Neuroepithelial Tissue
Jeong-Hoo Kim / University of Ulsan College of Medicine, Asan Medical Center, Korea
 
15:40-15:55    A New Expression Mode of Magnetic Brain Activities :Gradient Magnetic Field Topography and its Movie Display, especially in Tumor Related Epilepsy Cases
Kaoru Kurisu / Hiroshima University Hospital, Japan
 
15:55-16:10    Upregulation of WW Domain-Containing Oxidoreductase WOX1 in Certain Types of Meningioma and Astrocytoma
Ming-Fu Chiang / Mackay Memorial Hospital, Taiwan
 
16:10- 17:55 Oral Presentation 13 10F, Auditorium
Session 24:  Chemotherapy  
16:10-16:25    The Phase II Study of Multi-drug Chemotherapy for Low-Grade Gliomas in Children
Young Shin Ra / University of Ulsan, Korea
 
16:25-16:40   Chemotherapy for Malignant Glioma Patients Based on in vitro Chemo-Sensitivity Assay
Jun-ping Zhang / Cancer Center, Sun Yat-sen University, China
 
16:40-16:55   Clinical Efficacy and Toxicity of Concurrent Chemoradiotherapy in Malignant Gliomas
Seung-Ho Yang / The Catholic University of Korea, Korea
 
16:55-17:10   MGMT Activity as a Prognostic Factor in Temozolomide Therapy for Glioblastoma. Ta-Chih Tan / The University Clinic of Mainz, Germany
 
17:10-17:25   Reveral (Removal)of Drug Resistance of Human Glioma Cells by MGMT Antisense RNA
Jin Peng / The Second Hospital of ShanDong University, China
 
17:25-17:40   Postsurgical Adjuvant Therapy for Intracranial Germ Cell Tumor-Results of Pilot Study
Sin-Soo Jeun / The Catholic University of Korea, Korea
 
17:40-17:55   Suppression of C6 Glioma Proliferation by co-Culture with BMSC
JangBo Lee / College of Medicine, Korea University, Korea
 
11:00- 12:00 Special Lecture 15 & Oral Presentation 14 12F, Sky Lounge
Session 25: Basic Research  
11:00-11:20    Microarray and Biochemical Analysis of Lovastatin-induced Apoptosis in Human Glioblastoma Cell Lines: its Synergistic Effect with a Tumor Necrosis Factor
Wai Sang Poon / Prince of Wales Hospital, The Chinese University of Hong Kong, China
 
11:20-11:40   Suicide Gene Therapy for Malignant Gliomass Using Neural Stem Cells
Kyung-Gi Cho / Ajou University School, Korea
 
11:40-11:55   Co-registration of Molecular and Morphological Information: A Feasibility Study on Small Animal Model with microPET and MR imaging
Chin-Chin Yang/ National Yang-Ming University, Taiwan
 
12:30- 13:30 Oral Presentation 15 12F, Sky Lounge
Session 26:  Molecular Diagnosis  
12:30-12:45    Gene Expression Profiling in Intracranial Germ Cell Tumors
Ryo Nishikawa / Research Center for Genomic Medicine, Saitama Medical School, Japan
 
12:45-13:00   Immunohistochemical Markers for Evaluating Prognosis of Pediatric Medulloblastomas
Dong-Seok Kim / Yonsei University College of Medicine, Korea

 
13:00-13:15   Molecular Genetic Alterations on Ependymoma
Mizuhiko Terasaki / Kurume University School of Medicine, Japan
 
13:15-13:30   Usability of Tumor DNA Analysis in Astrocytic Tumors
Motohiko Maruno / Osaka University Graduate School of Medicine, Japan
 
13:30- 14:30 Oral Presentation 16  12F, Sky Lounge
Session 27:  Molecular Dx & Basic Research
 
13:30-13:45    Grade II-IV Gliomas are Classified into Clinically Relevant Subgroups by Genetic Profile
Yuichi Hirose / Keio University, Japan
 
13:45-14:00    Quantitative Measurement of Quality Outcome in Malignant Glioma Patients Using Time to KPS60 (TTK60) and TTK50 
Yoshitaka Narita / National Cancer Center Hospital, Japan
 
14:00-14:15   The Role of Matrix Metalloproteinase and Tissue Inhibitor of Matrix
Metalloproteinase in Microcystic Meningioma
Chul-Kee Park / Seoul National University College of Medicine, Korea
 
14:15-14:30    The Effects of n-butylidenephthalide on DBTRG Human GBM Cell Line and RG2 Cell Line in Vitro
Tsung-Lang Chiou / Tzu-Chi General Hospital., Taiwan
 
14:30 - 14:40 Coffee Break 10F, Chang Chin Room
14:40- 16:10 Special Lecture 16 12F, Sky Lounge
Session 28:   Radiotherapy  
14:40-15:10    Advances of Particle Beam Therapy and Boron Neutron Capture Therapy, and their Application in Neuro-Oncology in Japan
Mitsuyuki Abe / Hyogo Ion Beam Medical Center, Japan
 
15:10-15:40    The Target Volume Delineation in Glioblastoma Multiforme and the Consequences for Conformal Radiotherapy.
Ion-Christian Kiricuta / St. Vincenz-Hospital, Limburg, Germany
 
15:40-16:00    Toward a New Way of Molecular-targeted Radiotherapy using HDAC
Inhibitor-mediated Radiosensitization
Il Ham Kim / Seoul National University College of Medicine, Korea
 
16:00-16:20 Primary Central Nervous System Lymphoma(PCNSL)in Japan: Nationwide Survey Results from 1985 to2004
Yuta Shibamoto / Nagoya City University, Japan
 
16:20-16:40  Do we need Radiobiology in Radiosurgery
Yee-Min Jen / Tri-Service General Hospital Taiwan
 
16:40- 16:50 Coffee Break 10F, Chang Chin Room
16:50 - 18:00 Special Lecture 17 & Oral Presentation 17                    12F, Sky Lounge
Session 29: Radiotherapy  
16:50-17:10 Effects of BNCT on Malignant Gliomas Using Epithermal Neutron and 2 Boron Compounds
Shin-Ichi Miyatake / Osaka Medical College and Kyoto University Research Reactor Institute, Japan
 
17:10-17:25   Intra-opearative Boron Neutron Capture Therapy (BNCT) Using Epithermal Neutron Beams in Patients with Malignant Glioma  - Correlation between BNCT Radiation Dose and Radiation Injury, Clinical Outcome
Teruyoshi Kageji / School of Medicine, The University of Tokushima, Japan
 
17:25-17:40   Analysis of Boron Distribution in Vivo for BNCT Using Two Different Boron Compounds by Secondary Ion Mass Spectroscopy
Kunio Yokoyama / Osaka Medical College, Japan
 
17:40-17:55  Intracellular Targeting of Sodium Mercaptoundecahydrododecaborate (BSH) to Malignant Glioma by Transferrin-PEG Liposomes, for Boron Neutron-Capture Therapy (BNCT)
Atsushi Doi / Osaka Medical College, Japan
 
18:00- 18:10 Closing Remarks 10F, Auditorium
19:00- 22:00  Presidential Dinner  Really Good Seafood Restaurant  
   
  BACK | HOME | TOP